J1655 — Injection, tinzaparin sodium, 1000 iu
J1655 is a HCPCS Level II code for injection, tinzaparin sodium, 1000 iu. It belongs to the Drugs Administered Other Than Oral Method section. It was terminated on December 31, 2025 and is not valid on new claims.
This code has been terminated
CMS terminated J1655 on December 31, 2025. It stays in the file as history — a claim you are auditing from before that date may legitimately carry it — but it must not appear on a new claim. The adjacent codes below are the usual place to look for its replacement.
Medicare coverage: Carrier judgment
Coverage is decided by your Medicare contractor, not by national policy. Whether this is paid depends on the LCD for your jurisdiction and on what the documentation supports.
From the coverage field of the CMS Alpha-Numeric HCPCS File, release 2026Q3-Jul. This states Medicare’s position on the code, not on your particular claim.
The CMS record for J1655
- Long descriptor
- Injection, tinzaparin sodium, 1000 iu
- Short descriptor
- Tinzaparin sodium injection
- Added
- January 1, 2002
- Terminated
- December 31, 2025
- BETOS
- O1E
- Pricing indicator
- 51 — Other
The official wording. This is what the code means.
CMS's 28-character form, which is what shows up on a remittance advice.
When CMS introduced the code.
When CMS retired it.
Berenson-Eggers Type of Service — CMS's own analytic grouping.
Drugs.
Codes adjacent to J1655
HCPCS has no hierarchy — related items simply sit next to each other in the numbering. If J1655 is not quite right, the correct code is very often within a few positions of it.
- J1632Injection, brexanolone, 1 mg
- J1640Injection, hemin, 1 mg
- J1642Injection, heparin sodium, (heparin lock flush), per 10 units
- J1643Injection, heparin sodium (pfizer), not therapeutically equivalent to j1644, per 1000 units
- J1644Injection, heparin sodium, per 1000 units
- J1645Injection, dalteparin sodium, per 2500 iu
- J1650Injection, enoxaparin sodium, 10 mg
- J1652Injection, fondaparinux sodium, 0.5 mg
- J1670Injection, tetanus immune globulin, human, up to 250 units
- J1675Injection, histrelin acetate, 10 micrograms
- J1700Injection, hydrocortisone acetate, up to 25 mg
- J1710Injection, hydrocortisone sodium phosphate, up to 50 mgterminated
- J1720Injection, hydrocortisone sodium succinate, up to 100 mg
- J1725Injection, hydroxyprogesterone caproate, 1 mgterminated
- J1726Injection, hydroxyprogesterone caproate, (makena), 10 mg
- J1729Injection, hydroxyprogesterone caproate, not otherwise specified, 10 mg
Questions about J1655
What is HCPCS code J1655?
J1655 is a HCPCS Level II code for injection, tinzaparin sodium, 1000 iu. It sits in the Drugs Administered Other Than Oral Method section.
Does Medicare cover J1655?
The CMS HCPCS file marks J1655 as "Carrier judgment". Coverage is decided by your Medicare contractor, not by national policy. Whether this is paid depends on the LCD for your jurisdiction and on what the documentation supports.
Is J1655 still valid?
No. J1655 was terminated on December 31, 2025 and should not be used on new claims.